Table 1.
Target products (CRT) and comparator group products
| Target Product/Category | ASI-MV Product Selection Options |
|---|---|
| CRT ER opioid category | OxyContin (reformulated; Purdue Pharma L.P., Stamford, CT, USA) |
| OxyNEO (reformulated; Purdue Pharma Canada, Pickering, ON, Canada) | |
| Opana ER (reformulated; Endo Pharmaceuticals Inc., Malvern, PA, USA) | |
| Nucynta ER (Depomed, Inc. Newark, CA, USA) | |
| Non-CRT versions of CRT category | Original or generic oxycodone ER |
| Original or generic oxymorphone ER | |
| Nucynta IR (Depomed, Inc. Newark, CA, USA) | |
| Original or generic oxycodone ER | Original OxyContin (Purdue Pharma L.P., Stamford, CT, USA) |
| Xartemis XR (Mallinckrodt Pharmaceuticals, Inc., Hazelwood, MO, USA) | |
| Apo-oxycodone CR (Apotex Inc., Ontario, Canada) | |
| Co-oxycodone CR (Actavis [formerly Cobalt Pharmaceuticals Company], Mississauga, Canada) | |
| All morphine ER (excluding EMBEDA) | KADIAN (Actavis Pharma, Inc. Parsippany, NJ, USA) |
| AVINZA (Pfizer Inc., New York, NY, USA) | |
| Oramorph SR (Roxane Laboratories, Inc., Columbus, OH, USA) | |
| MS Contin (Purdue Pharma L.P., Stamford, CT, USA) | |
| Other morphine ER products | |
| Original or generic oxymorphone ER | Opana ER (original formulation; Endo Pharmaceuticals Inc., Malvern, PA, USA) |
| Generic ER oxymorphone | |
| Oxycodone IR SE | Roxicodone (Mallinckrodt Pharmaceuticals, Damastown, Mulhuddart, Dublin 15, Ireland) |
| Generic oxycodone IR SE |
CRT = crush-resistant tablet; ER = extended-release; IR = immediate-release; SE = single entity; SR = sustained-release.